Join to View Full Profile
11550 Indian Hills RdSuite 341Mission Hills, CA 91345
Phone+1 818-365-0606
Fax+1 818-898-0205
Dr. Smyth-Medina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 1991 - 1994
Maimonides Medical CenterInternship, Transitional Year, 1989 - 1990
Autonomous Metropolitan University XochimilcoClass of 1987
Certifications & Licensure
CA State Medical License 1990 - 2026
American Board of Ophthalmology Ophthalmology
Clinical Trials
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation Start of enrollment: 2014 May 01
- A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease Start of enrollment: 2021 Jan 11
Publications & Presentations
PubMed
- Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.Barry A Schechter, Maitee Urbieta, Jason Bacharach, Melissa Toyos, Robert Smyth-Medina
Clinical Ophthalmology. 2022-01-01 - 6 citationsSafety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.David Wirta, Michael S Korenfeld, Shane Foster, Robert Smyth-Medina, Jason Bacharach
Clinical Ophthalmology. 2021-10-08 - 10 citationsRapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.Jason Bacharach, David Wirta, Robert Smyth-Medina, Michael S Korenfeld, Shane R Kannarr
Clinical Ophthalmology. 2021-06-25
Journal Articles
- Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration with Visual Field in Acquired PtosisCharles B Slonim, Michael S Korenfeld, Robert Smyth-Medina, David L Wirta, JAMA Ophthalmology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
